Andrew Armstrong is a technology enthusiast, business owner, and digital growth strategist based in the San Francisco Bay Area.
Andrew Armstrong is a technology enthusiast, business owner, and digital growth strategist based in the San Francisco Bay Area.
less
Latest Comments
Death, Economics And Coronavirus
That's ridiculous. Of course the pandemic was the primary factor for decimating NYC. But unlike the author, no matter how famous he may be, I do believe that the city will bounce back. New York'ers don't roll over and give up. But it could take a year or two before it fully recovers.
Moderna In Talks To Supply 80M Doses Of Coronavirus Vaccine To European Commission
When this news spreads, It will be a massive squeeze.
NYC Is Dead Forever… Here’s Why
I usually read your articles to get a good laugh but this is downright depressing!
Fortnite Is Gone
One important question that hasn't been answered by @[Shelly Palmer](user:4838) in this article is this - are the millions of players that had already installed the game, still able to access it? Is it still on their iPads and phones and ready to play? Not sure Google and Apple want millions of addicted players getting angry at them for taking away their drug of choice!
The US Virus Problem Is Going From Bad To Worse: But There Is One Bright Ray Of Hope - Testing
This doesn't sound very convincing to me at all. I agree the current tests are problematic since they give a lot of false test results and are expensive. More importantly, they are in short supply since they contain some hard to come by components. But a "more than 50%" chance of correctly telling you if you are infected is horrible. How much more than 50%? 51%? You'll have almost as good odds flipping a coin.
How To Take Advantage Of A Second Great Opportunity
This is a refreshingly honest assessment of what it actually takes to invest and win in the market. There are no shortcuts, research is critical.
Is Gold In The Midst Of A 30-Year Bull Market?
The pandemic is the best thing that's happened to gold in a long time.
Protalix BioTherapeutics Pipeline Progress
True but it does sound promising. Like you, I'd be curious to see more info about the actual financials. But there is risk with every investment, and the greater the risk, the greater the potential payout.
Protalix BioTherapeutics Pipeline Progress
Good article, nicely done. I will be checking out $PLX.
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Thanks. You should get him to be a contributor here!